Sign in / Join Now
ETFs & Funds
Roy Manning III
continues to hold on as we wait for stage
trial to fill up. Offers a cure for Enlarged Prostate that works twice as well as pills.
Add a reply...
Latest StockTalks »
people get NYMX breaking news and analysis by email alert.
Get email alerts on NYMX »
Nymox Pharmaceutical Corporation
Get latest price
From other sites
Nymox Reports Additional Positive Results From Completed Fexapotide BPH Phase 3 Studies Showing Significant Early Response And First-Line Efficacy
at TheStreet (Nov 29, 2016)
Nymox Reports Successful New Phase 3 Long-Term Fexapotide Repeat Injection BPH Trial Results: Lasting Symptomatic Improvement Up To 6 Years After Single Repeated Treatment
at TheStreet (Oct 11, 2016)
Nymox's New Phase 3 Long-Term U.S. Results For Prostate Enlargement Drug Fexapotide Show
at TheStreet (Aug 29, 2016)
Jabbing a Needle in the Overinflated Nymox Prostate Drug Hype
at TheStreet (Aug 26, 2016)
Why Nymox Pharma (NYMX) Closed the Day Up 83%
at Zacks.com (Aug 24, 2016)